SCHEMBL7417562

SCHEMBL7417562

CCOc1ccc(S(=O)(=O)c2ccccc2)cc1CBr

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
ABCB1 P08183 1/20 0.41
ABCC1 P33527 1/20 0.41
MAPT P10636 3/20 0.41
POLB P06746 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTR6 P50406 2/20 0.41
SFRP1 Q8N474 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
LMNA P02545 3/20 0.39
MAPK1 P28482 3/20 0.39
RAB9A P51151 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416443 0.83 MMP2 (0.47) TP53ALDH1A1L3MBTL1LMNAMAPK1
SCHEMBL8058697 0.81 HTR6 (0.46) ABCB1ABCC1MAPTPOLBSMN1; SMN2
SCHEMBL7414743 0.81 HTT (0.53) ABCB1ABCC1MAPTPOLBSMN1; SMN2
Biphenyl SCHEMBL15562954 0.78 POLB (0.51) MAPTPOLBALDH1A1HTR6SFRP1
SCHEMBL19207384 0.78 HTR6 (0.52) MAPTPOLBSMN1; SMN2ALDH1A1HTR6
SCHEMBL20847652 0.73 MEN1 (0.66) TP53MAPTSMN1; SMN2ALDH1A1HTR6
SCHEMBL12222501 0.72 NPBWR1 (0.56) MAPTPOLBSMN1; SMN2ALDH1A1MEN1
SCHEMBL8061989 0.71 HTR6 (0.45) TP53ABCB1ABCC1MAPTPOLB
SCHEMBL8061991 0.71 HTR6 (0.45) TP53ABCB1ABCC1MAPTPOLB
SCHEMBL561755 0.70 L3MBTL1 (0.60) MAPTPOLBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163214-A1 GAMMA-KETOACID DIPEPTIDES AS INHIBITORS OF CASPASE-3 Merck Frosst Canada & Co. (CA) 2001-12-19 EP disclosed
US-6225288-B1 IMPLICATED IN MODULATING APOPTOSIS; TREATMENT OF:CARDIAC AND CEREBRAL ISCHEMIA/REPERFUSION INJURY, SPINAL CORD INJURY AND ORGAN DAMAGE DURING TRANSPLANTATION, CHRONIC NEURODEGENERATIVE DISEASES, IMMUNODEFICIENCY, DIABETES, ALOPECIA, AGING MERK FROSST CANADA & CO. (CA) 2001-05-01 US disclosed
WO-2000055127-A1 GAMMA-KETOACID DIPEPTIDES AS INHIBITORS OF CASPASE-3 MERCK FROSST CANADA & CO. (CA) 2000-09-21 WO disclosed